LEGN

Legend Biotech Corporation American Depositary Shares

Nasdaq · usd

$20.70+1.43 (+7.42%)

As of 2:22:31 PM EDT on Oct 26, 2026 · 15-minute delayed

Legend Biotech Corporation American Depositary Shares (LEGN) trades at $20.70 (+7.42%) as of 2:22:31 PM EDT on Oct 26, 2026, +8.32% over the past month. Market cap is $3.75B, with 7.1 days to cover in short interest.

Stock performance

How Legend Biotech Corporation American Depositary Shares (LEGN) stock has performed from one day to one year, with its 52-week range.

+8.32%

+$1.59 over 1D

1D: +7.42%
1W: +10.99%
1M: +8.32%
YTD: -4.78%
1Y: -35.55%
52-wk range: $16.24 – $37.50

Key statistics

Today's trading snapshot for LEGN: day range, open, previous close, volume and market cap.

Day range: $19.08 – $21.04
Open: $19.17
Prev close: $19.27
Volume: 1.61M
Market cap: $3.75B
Shares out: 193.77M

Insider buying and selling

In the 12 months to Oct 26, 2026, 2 LEGN insiders reported open-market sales of $347.7K across 2 filings; no open-market purchases were filed.

Who traded LEGN, and when

Sale

LEGN daily closelast $20.70

Corazon (Corsee) D. Sanders · Director

$258.9K sold

Patrick John Casey · Director

$88.8K sold

One row per insider; marks sit at the SEC filing date, sized by dollar value.

See who traded and when →

LEGN short interest

How heavily LEGN is shorted: shares short, days to cover and average daily volume.

Days to cover: 7.1
Short interest: 16.39M
Avg volume: 2.31M

As of Sep 30, 2026 · reported to FINRA twice monthly.

LEGN news

The latest news and headlines about Legend Biotech Corporation American Depositary Shares (LEGN).

Why Is Legend Biotech Stock Falling Thursday?
negativeBenzinga· Jun 18, 2026
Legend Biotech Corporation Announces Pricing of Public Offering
positiveGlobeNewswire Inc.· Jun 17, 2026
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
positiveGlobeNewswire Inc.· Jun 14, 2026
Why Legend Biotech Stock Crushed the Market on Monday
positiveThe Motley Fool· Apr 20, 2026
Arcutis Stock Is Up 100% in a Year but Here’s Why One Fund Still Sold 1 Million Shares
positiveThe Motley Fool· Dec 23, 2025

Frequently asked questions

What is the Legend Biotech Corporation American Depositary Shares (LEGN) stock price today?

Legend Biotech Corporation American Depositary Shares (LEGN) is trading at $20.70 (+7.42% on the day) as of 2:22:31 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Legend Biotech Corporation American Depositary Shares?

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications.

What is the short interest in LEGN?

As of Sep 30, 2026, LEGN has 16.39M shares short and 7.1 days to cover.

What exchange is LEGN listed on?

Legend Biotech Corporation American Depositary Shares (LEGN) trades on Nasdaq in USD.

Build with AI

Build an analysis of LEGN with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Claude ChatGPT

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a LEGN analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.